Fenoldopam and Splanchnic Perfusion During Cardiopulmonary Bypass

NCT00747331 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Complications
Cardiopulmonary Bypass

Interventions

DRUG: Fenoldopam mesilate
DRUG: Placebo

Sponsor

IRCCS Policlinico S. Donato